Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Statistics

Total Valuation

OSL:NYKD has a market cap or net worth of NOK 1.07 billion. The enterprise value is 591.07 million.

Market Cap	1.07B
Enterprise Value	591.07M

Important Dates

The last earnings date was Wednesday, May 27, 2026.

Earnings Date	May 27, 2026
Ex-Dividend Date	n/a

Share Statistics

OSL:NYKD has 326.55 million shares outstanding.

Current Share Class	326.55M
Shares Outstanding	326.55M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+2.86%
Owned by Insiders (%)	13.39%
Owned by Institutions (%)	31.92%
Float	169.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	197.19
PB Ratio	1.25
P/TBV Ratio	1.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.07
EV / Sales	109.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.11

Financial Position

The company has a current ratio of 12.66, with a Debt / Equity ratio of 0.03.

Current Ratio	12.66
Quick Ratio	12.66
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-241.94

Financial Efficiency

Return on equity (ROE) is -13.46% and return on invested capital (ROIC) is -76.23%.

Return on Equity (ROE)	-13.46%
Return on Assets (ROA)	-14.34%
Return on Invested Capital (ROIC)	-76.23%
Return on Capital Employed (ROCE)	-30.82%
Weighted Average Cost of Capital (WACC)	8.89%
Revenue Per Employee	95,001
Profits Per Employee	-2.55M
Employee Count	59
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-33.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +99.15% in the last 52 weeks. The beta is 0.86, so OSL:NYKD's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+99.15%
50-Day Moving Average	3.18
200-Day Moving Average	2.58
Relative Strength Index (RSI)	52.10
Average Volume (20 Days)	1,013,044

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:NYKD had revenue of NOK 5.42 million and -145.20 million in losses. Loss per share was -0.47.

Revenue	5.42M
Gross Profit	5.42M
Operating Income	-268.62M
Pretax Income	-178.30M
Net Income	-145.20M
EBITDA	-261.57M
EBIT	-268.62M
Loss Per Share	-0.47

Balance Sheet

The company has 499.45 million in cash and 22.71 million in debt, with a net cash position of 476.74 million or 1.46 per share.

Cash & Cash Equivalents	499.45M
Total Debt	22.71M
Net Cash	476.74M
Net Cash Per Share	1.46
Equity (Book Value)	852.31M
Book Value Per Share	2.61
Working Capital	496.19M

Cash Flow

In the last 12 months, operating cash flow was -279.52 million and capital expenditures -77,914, giving a free cash flow of -279.60 million.

Operating Cash Flow	-279.52M
Capital Expenditures	-77,914
Depreciation & Amortization	6.75M
Net Borrowing	-11.00M
Free Cash Flow	-279.60M
FCF Per Share	-0.86

Margins

Gross Margin	100.00%
Operating Margin	-4,960.61%
Pretax Margin	-3,292.63%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 29.76%.

Dividend Per Share	1.00
Dividend Yield	29.76%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	29.76%
Earnings Yield	-13.60%
FCF Yield	-26.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 7, 2020. It was a forward split with a ratio of 5.

Last Split Date	Jul 7, 2020
Split Type	Forward
Split Ratio	5

Scores

OSL:NYKD has an Altman Z-Score of 6.37.

Altman Z-Score	6.37
Piotroski F-Score	n/a